Teva acquisition boosts market

Teva rose strongly on the acquisition of NuPathe, while Bezeq recorded the strongest gain on the Tel Aviv 25 Index.

By AVIV LEVY/GLOBES
January 21, 2014 22:20
Teva Pharmaceutical plant is seen in Jerusalem

Teva 150. (photo credit: REUTERS/Ronen Zvulun)


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Israel Weather
  • 15 - 30
    Beer Sheva
    18 - 25
    Tel Aviv - Yafo
  • 15 - 26
    Jerusalem
    16 - 25
    Haifa
  • 20 - 36
    Elat
    17 - 32
    Tiberias